A practical reference on drug affinity complex: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-19 and is reviewed periodically as new material appears.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Although they disliked each other as children, she and Erasmas become romantically involved in the course of the story. Jad: A Millenarian fraa from the Concent of Saunt Edhar. Jad is summoned to the Convox at the same time of Erasmas, but tells Erasmas to look for Orolo instead of traveling directly to the Convox. Jad is a participant in philosophical discussions at the Convox and plays a key role in the mission to the alien ship. It is hinted that he is hundreds of years old and possesses the ability to be conscious within multiple parallel universes. Cord: Erasmas' half-sister and a machinesmith who lives near the Concent of Saunt Edhar. She accompanies Erasmas on his search for Orolo. She and Yul become romantically involved in the course of the story. Sammann: A member of a social caste of computer experts from the Concent of Saunt Edhar who accompanies Erasmas on his search for Orolo. He provides technological support and knowledge for Erasmas' companions throughout the story. Yulassetar Crade (nickname "Yul"): A wilderness guide who joins the expedition to find Orolo. He and Cord become romantically involved in the course of the story. Ganelial Crade (nickname "Gnel"): A religious man who volunteers to drive the avout to the Convox, before joining the search for Orolo. Erasmas mistrusts Gnel at first, but becomes friends over the course of the story. Jules Verne Durand: A linguist from Laterre who infiltrates the Convox to gather information for the aliens. He defects to the Arbrans and joins the mission to the alien ship.
=== Syrian transitional government (2024–present) === Following the fall of the Assad regime on 8 December 2024, the People's Assembly published a statement calling that day a "historic day in the lives of all Syrians", stating that it would work towards ensuring the upholding of the rule of law without discrimination. The statement included the new coat of arms of Syria, adorned with the flag of the Syrian opposition. On 11 December, the Ba'ath Party indefinitely halted all activities. The following day, the Syrian caretaker government suspended the assembly and constitution for a three-month transitional period. The People's Assembly was dissolved on 29 January 2025 when plans to establish an interim legislative council were announced by the Syrian transitional government. Following the adoption of the Constitutional Declaration of the Syrian Arab Republic, a provisional parliament called the "People's Assembly" was established to serve as the interim parliament during the five-year transition, overseeing the drafting of a new permanent constitution. The president selects one-third of the People's Assembly members, with the remaining two-thirds being elected through commissions supervised by a committee designated by the president. A presidential decree issued on 2 June 2025 established the Higher Committee for People's Assembly Elections. The 11-member committee is responsible for overseeing the formation of electoral sub-committees, which will elect two-thirds of the members of the People's Assembly.
== Awards and honors == Fulbright fellowship for research in pediatric hematology Honorary Doctorate of Science from William Woods College (1972) Honorary service award from the Ohio State University Home Economics Alumni Association Honorary member of the Turkish Society of Hematology Selected as a "Woman of Achievement" by the Group Action Council of Metropolitan St. Louis (1947)
=== The glutamate family of amino acids === The glutamate family of amino acids includes the amino acids that derive from the amino acid glutamate. This family includes: glutamate, glutamine, proline, and arginine. This family also includes the amino acid lysine, which is derived from α-ketoglutarate. The biosynthesis of glutamate and glutamine is a key step in the nitrogen assimilation discussed above. The enzymes GOGAT and GDH catalyze the nitrogen assimilation reactions. In bacteria, the enzyme glutamate 5-kinase initiates the biosynthesis of proline by transferring a phosphate group from ATP onto glutamate. The next reaction is catalyzed by the enzyme pyrroline-5-carboxylate synthase (P5CS), which catalyzes the reduction of the ϒ-carboxyl group of L-glutamate 5-phosphate. This results in the formation of glutamate semialdehyde, which spontaneously cyclizes to pyrroline-5-carboxylate. Pyrroline-5-carboxylate is further reduced by the enzyme pyrroline-5-carboxylate reductase (P5CR) to yield a proline amino acid. In the first step of arginine biosynthesis in bacteria, glutamate is acetylated by transferring the acetyl group from acetyl-CoA at the N-α position; this prevents spontaneous cyclization. The enzyme N-acetylglutamate synthase (glutamate N-acetyltransferase) is responsible for catalyzing the acetylation step. Subsequent steps are catalyzed by the enzymes N-acetylglutamate kinase, N-acetyl-gamma-glutamyl-phosphate reductase, and acetylornithine/succinyldiamino pimelate aminotransferase and yield the N-acetyl-L-ornithine.
Sources: en.wikipedia.org
Deoxycholic acid is a bile acid. Deoxycholic acid is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria. The two primary bile acids secreted by the liver are cholic acid and chenodeoxycholic acid. Bacteria metabolize chenodeoxycholic acid into the secondary bile acid lithocholic acid, and they metabolize cholic acid into deoxycholic acid. There are additional secondary bile acids, such as ursodeoxycholic acid. Deoxycholic acid is soluble in alcohol and acetic acid. When pure, it exists in a white to off-white crystalline powder form. Deoxycholic acid is available as a generic medication in the United States as of April 2021, sold under the brand name Kybella among others.
The prevalence of undernutrition is highest among children under five. In 2024, 150.2 million children under five years old were stunted, 42.8 million were wasted, and 35.5 million were overweight or obese. In 2021, an estimated 45% of deaths in children were linked to undernutrition. As of 2020, the prevalence of wasting among children under five in South Asia was reported to be 16% moderately or severely wasted. As of 2022, UNICEF reported this prevalence as having slightly improved, but still being at 14.8%. India has one of the highest burdens of wasting in Asia with over 20% wasted children. However, the burden of undernutrition among under-five children in African countries is much higher. A pooled analysis of the prevalence of chronic undernutrition among under-five children in East Africa was identified to be 33.3%. This prevalence of undernutrition among under-five children ranged from 21.9% in Kenya to 53% in Burundi. In Tanzania, the prevalence of stunting, among children under five varied from 41% in lowland and 64.5% in highland areas. Undernutrition by underweight and wasting was 11.5% and 2.5% in lowland and 22.% and 1.4% in the highland areas of Tanzania respectively. In South Sudan, the prevalence of undernutrition explained by stunting, underweight and wasting in under-five children were 23.8%, 4.8% and 2.3% respectively. In 28 countries, at least 30% of children were still affected by stunting in 2022. Vitamin A deficiency affects one third of children under age 5 around the world, leading to 670,000 deaths and 250,000–500,000 cases of blindness.
=== EC 1.5.8 With a flavin or flavoprotein as acceptor === EC 1.5.8.1: dimethylamine dehydrogenase EC 1.5.8.2: trimethylamine dehydrogenase EC 1.5.8.3: sarcosine dehydrogenase EC 1.5.8.4: dimethylglycine dehydrogenase
=== 1994–1999: Rise and critical acclaim === Carrey played the lead role in Ace Ventura: Pet Detective which was released in February 1994 and went on to gross $72 million in the United States and Canada. Following its success and before the release of his next film, The Mask, which was anticipated to be another hit, Morgan Creek Productions paid him $5 million to reprise his role as Ace Ventura and New Line Cinema offered him $7 million to make a sequel to The Mask and paid him $7 million to appear in Dumb and Dumber, a nearly tenfold increase on his salary for Ace Ventura. The Mask, released in July 1994, grossed $351 million worldwide, and Dumb and Dumber, released in December 1994, was another commercial success, grossing over $270 million worldwide. Carrey received his first Golden Globe Award nomination for Best Actor for his work in The Mask and was voted second on Quigley's Top Ten Money Making Stars Poll, behind Tom Hanks. Carrey portrayed the Batman villain the Riddler in the Joel Schumacher-directed superhero film Batman Forever (1995). The film received mixed reviews, but was a box office success. He reprised his role as Ace Ventura in Ace Ventura: When Nature Calls which was also released in 1995. Like the original film, it was well received by the public, but poorly received by critics. It was a huge box-office success, earning $212 million worldwide in addition to breaking records, with a $40 million opening weekend. Carrey became the first comic actor to be paid an upfront salary of $20 million for his next film, The Cable Guy (1996).
== Personal life == In August 2016, Shaw married writer–producer Zach Strauss. Shaw has a son, Isaac Love, from a prior relationship with director and actor Mark Webber. Shaw and Webber share joint custody of Isaac.
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.